May 13 - 14, 2024
National Institutes of Health
Building 45
45 Center Drive
Bethesda, MD 20892
Natcher Auditorium

Building on the foundation of cell-free DNA prenatal testing, the field of liquid biopsy research has rapidly evolved, with uses spanning from early detection of cancer and monitoring of organ transplants. Unlike traditional biopsy methods that require invasive procedures to obtain tissue samples, liquid biopsies use simpler methods to detect disease markers, including cells themselves, in different biofluids, including blood, urine, and even cerebral spinal fluid. This less invasive approach allows for repeated monitoring over time.

Attending the conference will be an excellent opportunity to stay up-to-date on the latest developments and advancements in the field of liquid biopsies. Researchers and professionals from all over the world will be sharing their insights and results, and you'll have the chance to network with others in the field, providing valuable opportunities for collaboration, learning, and professional growth. Young investigators and trainees are especially encouraged to attend career roundtable discussions over lunch, and all attendees are invited to submit abstracts for poster sessions on both days of the conference as well as for consideration for short oral presentations. In keeping with NIH's mission to provide equitable and inclusive conference experiences, attendance is free -- there will be no registration fee for any attendees. This conference is open to members of the NIH community, academic researchers outside of the NIH, and members of pharma/industry.

Please watch your email for additional information leading up to the start of the conference. For any conference-related questions or to cancel your registration, please email conferenceplanning@mail.nih.gov


Registration is currently closed.